Molecular pathology of the X-linked hyper-immunoglobuin M syndrome: Detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand

被引:14
作者
Ameratunga, R
McKee, J
French, J
Prestidge, R
Fanslow, W
Marbrook, J
机构
[1] UNIV AUCKLAND,DEPT MOL MED,AUCKLAND 1,NEW ZEALAND
[2] STARSHIP CHILDRENS HOSP,AUCKLAND,NEW ZEALAND
[3] AUCKLAND HOSP,VIROL IMMUNOL LAB,AUCKLAND,NEW ZEALAND
[4] GREEN LANE HOSP,DEPT CARDIOL,AUCKLAND 3,NEW ZEALAND
[5] IMMUNEX CORP,SEATTLE,WA
关键词
D O I
10.1128/CDLI.3.6.722-726.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The X-linked hyper-immunoglobulin M syndrome (XHIM) is a primary immune deficiency disorder characterized by an inability to produce immunoglobulin isotypes other than immunoglobulin M (IgM) and IgD, Recently, a B-cell surface antigen (CD40) and its conjugate T-cell counterstructure (CD40 ligand) were shown to mediate immunoglobulin isotype switching in the presence of cytokines such as interleukin 4. Most patients with XHIM have been shown to have mutations of the extracellular domain of the CD40 ligand, sere we describe a novel point mutation of an intronic splice acceptor site which results in a complex splicing defect of the CD40 ligand in a patient with XHIM. In addition to two species of deleted transcripts, wild-type transcripts were also detected in this individual. The demonstration of wild-type CD40 ligand transcripts may be an explanation for precious observations suggesting that some XHIM patients are able to undergo immunoglobulin isotype switching in vivo.
引用
收藏
页码:722 / 726
页数:5
相关论文
共 23 条
  • [1] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME
    ALLEN, RC
    ARMITAGE, RJ
    CONLEY, ME
    ROSENBLATT, H
    JENKINS, NA
    COPELAND, NG
    BEDELL, MA
    EDELHOFF, S
    DISTECHE, CM
    SIMONEAUX, DK
    FANSLOW, WC
    BELMONT, J
    SPRIGGS, MK
    [J]. SCIENCE, 1993, 259 (5097) : 990 - 993
  • [2] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [3] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    [J]. CELL, 1993, 72 (02) : 291 - 300
  • [4] Ausubel FM., 2006, ENZYMATIC MANIPULATI
  • [5] BOYHAN A, 1992, J BIOL CHEM, V267, P2928
  • [6] CALLARD RE, 1994, J IMMUNOL, V153, P3295
  • [7] ACTIVATION OF HUMAN B-CELLS MEDIATED THROUGH 2 DISTINCT CELL-SURFACE DIFFERENTIATION ANTIGENS, BP35 AND BP50
    CLARK, EA
    LEDBETTER, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4494 - 4498
  • [8] CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM
    DISANTO, JP
    BONNEFOY, JY
    GAUCHAT, JF
    FISCHER, A
    DESAINTBASILE, G
    [J]. NATURE, 1993, 361 (6412) : 541 - 543
  • [9] Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035
  • [10] FANSLOW WC, 1992, J IMMUNOL, V149, P655